We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany.
- Authors
Koehler, Johanna; Ritzer, Barbara; Weidlich, Simon; Gebhardt, Friedemann; Kirchhoff, Chlodwig; Gempt, Jens; Querbach, Christiane; Hoffmann, Dieter; Haller, Bernhard; Schmid, Roland M.; Schneider, Jochen; Spinner, Christoph D.; Iakoubov, Roman
- Abstract
Additional treatment options for coronavirus disease (COVID-19) are urgently needed, particularly for populations at high risk of severe disease. This cross-sectional, retrospective study characterized the outcomes of 43 patients with nosocomial severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection with and without treatment using monoclonal SARS-CoV-2 spike antibodies (bamlanivimab or casirivimab/imdevimab). Our results indicate that treatment with monoclonal antibodies results in a significant decrease in disease progression and mortality when used for asymptomatic patients with early SARS-CoV-2 infection.
- Subjects
GERMANY; THERAPEUTIC use of monoclonal antibodies; DISEASE progression; SARS-CoV-2; COVID-19; CROSS-sectional method; CROSS infection; TERTIARY care; RETROSPECTIVE studies; TREATMENT effectiveness
- Publication
Infection, 2021, Vol 49, Issue 6, p1313
- ISSN
0300-8126
- Publication type
Article
- DOI
10.1007/s15010-021-01657-y